Remove Media Remove Safety Remove Topical
article thumbnail

FDA Issues Warning Letters to CBD Manufacturers Making “Over-The-Line” Health Claims

Canna Law Blog

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” For a complete list of questions and topics identified by the FDA, see here.

CBD 103
article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US Hemp Roundtable Analysis Of FDA CBD Report To Congress

Cannabis Law Report

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71
article thumbnail

Press Release: NEWAGE LAUNCHES ‘NHANCED HEMP TOPICALS IN AUSTRALIA AND NEW ZEALAND

Cannabis Law Report

KEY HIGHLIGHTS: NewAge launches its ‘NHANCED Hemp Topical Products in Australia and New Zealand. For investor inquiries about NewAge Beverages Corporation please contact: Media: Desiree Rosa, MULTIPLY. NHANCED Hemp Topical Products. DENVER, COLORADO, Dec. ” About NewAge Beverages Corporation (NASDAQ: NBEV ).

Topical 45
article thumbnail

Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™

Cannabis Law Report

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Media: Laura Radocaj. Chief Financial Officer.

Safety 40
article thumbnail

Travelers Institute Announces Fall 2021 Virtual Programming

Cannabis Law Report

Our upcoming lineup covers a wide range of topics that are relevant to both individuals and businesses – from politics and new legislation to public health issues, cybersecurity and technology advancements,” said Woodward. Media: Sperry Mylott, 860.277.5075. 22 – “High Risk? About the Travelers Institute. smylott@travelers.com.

article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. and are difficult to predict. cbdMD, Inc. John Weston. Director of Investor Relations.